Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Oncogene|July 30, 2026
PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapyChandra K Maharjan, Yi Liu, Yufeng Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine TumorsAaron T Scott, Michelle Weitz, Patrick J Breheny, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.
Molecular Cancer Therapeutics|April 21, 2026
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 InhibitorsJordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, et al.
The Journal of Experimental Medicine|February 9, 2024
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.
Pageof 6